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Recent  research  links  nutritional  exposures  early  in  life with  alterations  in  functional  immunity  that  per-
sist  beyond  childhood.  Here  we  investigate  predictors  of  antibody  response  to  polysaccharide  vaccines  in
a  cohort  of  Gambian  adults  with  detailed  records  from  birth  and  early  infancy  available.  320  adults  were
given  a  single  dose  of  a Vi polysaccharide  vaccine  for  Salmonella  typhi  and  a 23-valent  capsular  polysac-
charide  pneumococcal  vaccine.  Anti-Vi  antibody  levels  and  antibodies  against  4  pneumococcal  serotypes
(1,  5, 14  and  23F)  were  measured  in  serum  samples  collected  at baseline  and then  14  days  following  vac-
cination  and  compared  to  data  available  from  birth  and  early  infancy.  Post-vaccination  antibody  titresmmune programming
irth  weight
nfant growth
ambia
to  serotype  14  of  the  pneumococcal  vaccine  were  negatively  associated  with  rate  of growth  from  birth
to  three  months  of  age,  infant  weight  at 12  months  of  age  and  season  of  birth,  but no  other  associations
were  observed  with  early-life  exposures.  The  strongest  predictor  of  antibody  levels  was  pre-vaccination
antibody  titres,  with  adult  height  and  serum  neopterin  levels  at  time  of  vaccination  also implicated.
The  current  study  does  not  support  the hypothesis  that  nutritional  exposures  early  in life  consistently
compromise  antibody  response  to polysaccharide  vaccines  administered  in young  adulthood.. Introduction
The inter-relationship between nutritional status and immune
unction continues to be the focus of research and debate [1,2].
t is well documented that acute and chronic deﬁciency of both
acro- and micro-nutrients results in an impairment to a num-
er of components of the immune system [3] and supplementation
ith individual micronutrients has proven efﬁcacious as ther-
py for certain infectious morbidities; for instance vitamin A and
easles infection [4], and zinc and diarrhoeal disease [5]. More
ecent research also suggests that supplementation with spe-
iﬁc micronutrients may  have non-speciﬁc deleterious effects on
mmune function, with iron [6] and vitamin A [7] speciﬁcally impli-
ated. Further work to understand the mechanisms of these effects
s required.
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In addition to the effects of contemporaneous nutritional sta-
tus on human immune function, recent evidence from our group
and others suggests that nutritional status during fetal life and
early infancy may  be critical for immune development, with effects
persisting into adulthood. Using antibody response to vaccination
as a functional indicator of immunity, we  have previously shown
that adults born of a lower birth weight have a reduced anti-
body response to a polysaccharide vaccine (Typhim Vi) [8]. This
deﬁcit persisted following a second ‘booster’ dose of the vaccine
[9] but no such association with size at birth was observed with
either a protein (rabies) vaccine [8] or a polysaccharide-conjugate
(Hib)  vaccine [9]. This differential response suggests an early-life
programming effect on the generation of antibodies during a B-
cell-dependent immune response.
Much of the programming literature has focused on poor
maternal nutrition as the most likely candidate for these early-life
effects, and uses low birth weight as a proxy indicator for poor
nutrition in utero. However, low birth weight may also be predic-
tive of a number of post-natal factors that could also be implicated
Open access under CC BY license.in deﬁning later disease risk. Recent attention has focused on the
association between an infant’s rate of growth during early-infancy
and later disease risk, with faster rates of post-natal ‘catch-up’
growth implicated as a possible causative factor for certain chronic
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isease outcomes [10]. The current study was therefore designed
o investigate in more detail the relationship between nutritional
tatus early in life and response to vaccination in young adults.
ere, we investigate antibody response to two polysaccharide vac-
ines in a cohort of Gambian adults with detailed anthropometric
ata available from birth and from early infancy.
. Materials and methods
.1.  Study population
Since  1949, the UK Medical Research Council (MRC) has been
ollecting health and demographic data on the populations of three
illages (Keneba, Kantong Kunda and Manduar) in the rural West
iang region of The Gambia. From 1976, and with the establish-
ent of a permanent ﬁeld station in Keneba, this data collection has
ncorporated detailed information on maternal and infant health,
ncluding birth anthropometry and infant growth. In the current
tudy, our recruitment pool consisted of all adults, born in the three
tudy villages since 1976 and who were aged 18 years or older on
st January 2006. Subjects were excluded if they could not be traced
r were not accessible for follow up, if they were already enrolled
n another MRC  study or if they were known to be pregnant at the
ime of recruitment. Ethical approval for the study was given by
he Ethics Committee at the London School of Hygiene and Tropical
edicine and by the joint Gambian Government/MRC The Gambia
thics Committee. Informed written consent was  obtained from
ach individual participant.
The  study took place between February and May 2006. Sub-
ects were seen on two occasions, 14 days apart. At visit 1 (Day 0)
eight, height, waist and hip circumferences were measured using
tandard equipment. A single sample of fasted venous blood was
ollected for measurement of plasma leptin and serum neopterin:
eptin was measured as a proxy marker of adiposity and neopterin
s a marker of immune activation. This blood sample was addi-
ionally used for the assessment of pre-vaccination serum antibody
itres and for the preparation of a thick ﬁlm for detection of malaria
arasites by microscopy. Following blood collection, each subject
as given a single dose of a Vi polysaccharide vaccine for Salmonella
yphi (Sanoﬁ-Pasteur, Lyon, France) and a single dose of a 23-valent
apsular polysaccharide vaccine (Pneumo, Sanoﬁ-Pasteur, Lyon,
rance). Fourteen days later (Visit 2), a further venous blood sample
as collected for post-vaccination serum antibody titres.
.2.  Laboratory methods
Plasma  leptin and serum neopterin were measured at MRC
uman Nutrition Research, Cambridge UK. Leptin was  measured
y ELISA (R&D Systems, Abingdon, UK) and neopterin by a compet-
tive enzyme immunoassay principle (BRAHMS Atiengesellschaft,
erlin, Germany). Both analytes were measured in duplicate and
ollowing manufacturers’ guidelines.
Anti-Vi immunoglobulin G (IgG) analysis was conducted at the
aboratory of Developmental and Molecular Immunity, National
nstitutes of Child Health and Human Development, Bethesda, USA.
rieﬂy, microtitre plates were coated with Vi (0.2 g/well) puri-
ed from Citrobactor freundii and goat anti-human IgG (Jackson
mmuno Research Laboratories Inc., West Grove, PA) conjugated to
lkaline phosphatase were used for ELISA. The anti-Vi IgG standard
as a plasma sample from an adult vaccinated with Vi polysaccha-
ide typhoid vaccine (provided by Wendy Keitel, Baylor University,
ouston, TX). The Vi antibody content of this serum was  also
ssayed by a radioimmunoassay (RIA) by Pasteur Merieux Con-
aught. The antibody levels were expressed in ELISA units (EU)
nd the reference sera were assigned a value of 75 EU. All samples0 (2012) 4842– 4848 4843
were  run in duplicate. Antibody levels were calculated using Pro-
gram ELISA, version 12 (Center for Disease Control and Prevention,
Atlanta, GA). The lowest detectable level of the assay for anti-Vi
IgG was 0.1 EU. Prior to analysis, all data were log transformed,
and results are presented as geometric means. For anti-Vi antibody
levels, data are expressed as ELISA units (EU).
Pneumococcal capsular polysaccharide speciﬁc IgG levels were
measured at the WHO  Pneumococcal Serology Reference Lab at the
UCL Institute of Child Health, London, UK. Standard enzyme linked
immunosorbent assay methods [11] were used to quantify anti-
capsular IgG antibodies to four speciﬁc pneumococcal serotypes (1,
5, 14 and 23F). These serotypes were selected on the basis of fre-
quency of carriage within this population setting, 14 and 23F being
amongst the most common [12], and their importance in causing
invasive disease (1 and 5 account for >40% in a recent series of
pneumococci causing bacteraemia [13]).
2.3. Statistical analyses
Comparisons amongst group means were made using two-
sample t-tests. Vaccine data are presented as geometric means and
95% conﬁdence intervals (CIs). Sex speciﬁc z-scores were calculated
using UK reference data [14]. Associations between contemporary
measures and antibody response to vaccination were compared by
linear (for continuous variables) or logistic (for binary variables)
regression analysis. Response to vaccination was  assessed in rela-
tion to six early-life exposures (separate models); birth weight, low
birth weight (<2.5 kg) vs. normal birth weight (as a binary variable),
small for gestational age vs. appropriate for gestational age (as a
binary variable), rate of infant growth from birth to three months
of age, infant weight at 12 months of age and season of birth (har-
vest/wet season January–June; hungry/dry season July–December).
Rate of change in weight from birth to three months was calcu-
lated as the difference between sex-speciﬁc birth weight standard
deviation score and sex-speciﬁc weight at three months standard
deviation score. We  also looked at weight for age standard devia-
tion differences between three and six months of age and six and
12 months of age. Associations between these early-life exposures
and antibody responses were tested by multiple linear regression
analysis. Probability values <0.05 were considered to be statistically
signiﬁcant for all tests. All statistical analyses were performed using
DataDesk, version 6 for Windows, Data Description Inc., Ithaca, NY.
3. Results
3.1. Subject characteristics
A  total of 858 individuals met  the criteria for recruitment into
the current study. Of these, 78 were known to have died prior to
follow up, leaving a cohort of 781 to be traced. Of this number,
145 were excluded on the basis they were currently participating
in another ongoing study and three because they were conﬁrmed
to be pregnant by an MRC  midwife prior to the start of the study.
Of the remaining 633 individuals who  were eligible to participate,
241 were not available [dead (4), self-conﬁrmed as pregnant (45),
overseas (24), outside designated study area (58), not traceable
(50), traceable but unavailable for study (60)] and 72 did not con-
sent to participate. A total of 320 subjects (41% of 781 followed
up) consented and participated in the current study. Compared
to non-participants, participants were younger (22.2 y vs. 23.0 y;
p < 0.0001) and there were signiﬁcantly more males than females
(51.9% vs. 45.3%). No differences were observed between the par-
ticipants and non-participants in available early-life information
(data not presented). Table 1 details the early-life characteristics of
the subjects recruited. A total of 41 (12.8%) of subjects were born
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Table  1
Early-life variables.
Males (n = 166) Females (n = 154)
Birth weight (kg) 3.10 (0.42) 2.87 (0.41)a
Low birth weight (%) 8.43  17.5b
Gestational age (wks) 38.9  (1.43) 38.6 (1.56)
Small  for gestational age (%) 16.9 21.4
Hungry  season births (%) 51.8 53.9
Wt  at 3 months (kg) 5.92 (0.84) 5.35 (0.79)a
Change in z-score, birth to 3 months 0.43 (0.99) 0.36 (0.99)
Change  in z-score, 3–6 months −0.56 (0.72) −0.55 (0.67)
Change  in z-score, 6–12 months −0.84 (0.80) −0.72 (0.88)
Wt  at 12 months (kg) 8.28  (1.04) 7.65 (1.03)a
All data are means (±SD) or percentages of total. Hungry season = July–December
inclusive.
Gestational  age (and small for gestational age) data only available for n = 267 (83%)
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a Signiﬁcantly different from males ≤0.0001.
b Signiﬁcantly different from males ≤0.05.
f a low birth weight (<2.5 kg), and a higher proportion of these
ere female. Of these, 13 were born pre-term (<37 weeks gesta-
ion), although 9 had a missing gestational age. A total of 267 (83%)
f the cohort had gestational age assessments available. Using the
illiam’s reference data [15], 51 (19%) of these infants would be
onsidered small for gestational age (SGA). Male subjects were sig-
iﬁcantly heavier at three months and at 12 months of age, but the
ate of early growth, expressed as the sex-speciﬁc change in z-score
etween birth and three months of age, three to six months, or six
o twelve months did not differ between males and females.
Characteristics of the study participants at follow up are detailed
n Table 2. Male participants were signiﬁcantly taller and heav-
er than females, but had a lower mean Body Mass Index (BMI)
nd plasma leptin level. Signiﬁcantly more of the males lived in
rban areas of The Gambia compared to females, and the distri-
ution of month of study differed between the males and females
ecruited. No differences were observed in age, waist:hip ratio, or
erum neopterin levels between the male and female subjects.
.2.  Antibody response to vaccination
Pre- and post-vaccination geometric mean (95% CI) data for both
he pneumococcal and Vi vaccine are detailed in Table 3. A total of
12 subjects (37.2%) did not achieve antibody titres >3.52 EU fol-
owing Vi vaccination, the estimated level for 90% protection. Using
 post-vaccination anti-pneumococcal IgG titre of >0.35 g/mL,
he level considered indicative of putative protection, all subjects
chieved an adequate response to all serotypes.
Simple univariate regression analysis was used to test for unad-
usted associations between antibody response to vaccination and
able 2
ubject characteristics.
Males (n = 166) Females (n = 154)
Age (y) 22.1 (2.77) 22.6 (3.02)
Weight  (kg) 60.8 (8.67) 55.7 (8.69)a
Height (cm) 173.3 (722) 160.3 (6.77)a
BMI  (kg/m2) 20.2 (2.19) 21.7 (3.01)a
Waist:hip ratio 0.77 (0.04) 0.77 (0.05)
Plasma  leptin (ng/mL)b 0.73 (0.64–0.84) 9.68 (8.51–11.05)a
Rural living (%) 15.1% 31.8%b
Month of study F/M/A/M (%) 3.0/21.7/24.7/50.6 18.8/19.5/33.8/27.9a
Malaria parasite positive 2/166 0/154
Neopterin  (nmol/L) 7.37 (7.10–7.64) 7.51 (7.25–7.79)
ll data are means (±SD) or percentages of total. Leptin and neopterin data are
eported as geometric means (95% CI). Month of Study data are report as percent of
otal per month.
a Signiﬁcantly different from males ≤0.0001.
b Signiﬁcantly different from males ≤0.001.0 (2012) 4842– 4848
the contemporary variables measured at the time of vaccination;
sex, age, location (rural vs. urban), weight, height, BMI, plasma
leptin, month of study (February, March, April, May), malaria par-
asitaemia (+ve vs. −ve), and serum neopterin levels (Table 4).
Pre-vaccination antibody titres were also included as a potential
confounder in all of the models. Variables showing signiﬁcant asso-
ciations with antibody response to vaccination were then ﬁtted into
a multivariate model; those variables that remained signiﬁcant are
as detailed in Table 4. Only those variables that remained signiﬁ-
cant predictors of antibody response were then added to the models
looking at early-life inﬂuences on response to vaccination.
We  did not predict, a priori, that pre-vaccination antibody
levels would have such a strong inﬂuence on post-vaccination
antibody responses. However, and as pre-vaccination levels could
themselves be predicted by early life exposures (through immune
responses to infection), we repeated the analysis (a) looking
at predictors of pre-vaccination levels per se, and (b) removing
pre-vaccination levels from the ﬁnal model of predictors of post-
vaccination levels. Following adjustment for contemporary factors
shown to be associated with pre-vaccination levels, the only signiﬁ-
cant association observed was between infant weight at 12 months
of age and pre-vaccination levels to pneumococcal serotypes 5 and
23 (p = 0.028 and 0.016 respectively; analyses not presented). The
results of the regression analysis excluding pre-vaccination levels
are included in Table 5.
Associations between early-life exposures and antibody
responses to vaccination were tested by multiple linear regression
analysis, adjusting for the contemporary variables identiﬁed as pre-
dictive of antibody responses. Table 5 highlights the unadjusted
and adjusted results of multiple linear regression analysis using
birth weight, low birth weight (<2.5 kg) vs. normal birth weight,
rate of infant growth from birth to three months of age, infant
weight at 12 months of age, and season of birth (hungry vs. har-
vest) as dependent variables (separate models employed for each
variable). No signiﬁcant associations were observed between the
early-life data and antibody response to vaccination with either
a Vi polysaccharide vaccine or with serotypes 1, 5 and 23f of the
pneumococcal polysaccharide vaccine. For serotype 14, no associ-
ations were observed with birth weight or low birth weight, but
a trend towards signiﬁcance was  observed for infant growth from
birth to three months of age (negative trend), infant weight at 12
months of age (negative trend) and season of birth (higher in hun-
gry season births). The analyses were also performed using change
in weight-for-age standard deviation scores between three and six,
and six and twelve months of age. No signiﬁcant associations were
observed, with the exception of a marginally signiﬁcant relation-
ship between rate of growth between six and twelve months of
age and antibody response to serotype 14, when adjusted for pre-
vaccination antibody levels (  ˇ = −0.116, p = 0.043; other data not
presented).
4. Discussion
Recent research has highlighted a possible association between
nutritional status in early-life and development of the human
immune system, with long-term programming effects on immune
function inferred [16]. Studies in Gambian [17] and Bangladeshi
[18] infants have shown correlations between pre- and post-natal
nutritional and environmental exposures and development of the
thymus during early infancy. In The Gambia, these alterations in
thymic size were reﬂected by changes in both lymphocyte sub-
population counts [19] and in levels of signal-joint T-cell receptor
rearrangement circles (sjTREC), an indirect marker of thymic out-
put, suggesting an effect on thymic function [20]. Of importance,
this early-life effect appears to persist beyond infancy. Results from
S.E. Moore et al. / Vaccine 30 (2012) 4842– 4848 4845
Table 3
Pre-and post-vaccination antibody concentrations.
IgG anti Vi antibody
concentrations (EU)
IgG anti-pneumococcal
antibody concentrations
(g/mL)
Pre Post Type 1 Type  5 Type  14 Type 23F
Pre Post Pre Post Pre Post Pre Post
n 316 301 315 302 316 302 316 302 316 302
GM 0.56  7.19 1.28 10.17 1.92 6.45 8.49 45.5 1.62 7.01
95%  CI 0.49–0.63 6.11–8.46 1.18–1.40 9.05–11.4 1.76–2.09 5.83–7.13 7.46–9.67 40.9–50.5 1.45–1.81 6.23–7.88
Non  responder 37.2% 0% 0% 0% 0%
GM – geometric mean; EU – Elisa Units.
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tudies in adolescents from the Philippines [21] and in adults from
akistan [8,9] indicate a positive association between birth weight
nd antibody response to a Vi polysaccharide vaccine for S. typhi.
n the study in Pakistan, no association however was observed
n antibody response to either a rabies (protein) vaccine [8] or
olysaccharide conjugate (conjugated H. inﬂuenzae type b (Hib)
accine) vaccine [9]. These contrasting effects suggest that antibody
eneration to polysaccharide antigens, which have greater B-cell
nvolvement, may  be compromised by fetal growth retardation.
The  current study was speciﬁcally designed to explore the rela-
ionship between markers of both pre-and post-natal nutritional
tatus and antibody response to polysaccharide antigen vaccines
n adults born in rural Gambia. In this cohort of 320 young Gam-
ian adults, no associations were observed between birth weight,
ow birth weight (<2.5 kg), small for gestational age, rate of growth
rom birth to three months of age, infant weight at 12 months of
ge, or season of birth with antibody response to the Vi polysaccha-
ide vaccine or serotypes 1, 5 and 23f of the pneumococcal vaccine.
ntibody responses to serotype 14 of the vaccine however were
igher amongst infants who were smaller at 12 months of age and
howed slower growth between 3 and 12 months of age. In addi-
ion, infants born during July to December (the ‘hungry’ season)
ad higher antibody titres to serotype 14. The data from this study
ffer only limited support an early-life programming effect of early
utrition on antibody response to vaccination in adulthood within
his environment.
The  observed associations between early life exposures and
esponse to serotype 14 of the pneumococcal vaccine only are
ather difﬁcult to explain. Globally, serotype 14 is the most impor-
ant serotype causing disease worldwide, although carriage rates
ary between populations [12,22,23]. Of the 4 serotypes assessed
n the current study (1, 5, 14 and 23f), exposure to 23F and 14
re most likely similar and so early exposures during infancy
re unlikely to explain the difference. Technically, type 14 is the
purest’ serotype to assay, with little cross-reaction with other
erotypes when measured in ELISA (D Goldblatt, personnel com-
unication), but it is unlikely that this alone explains the observed
ifferences. Selection of serotypes was primarily based on car-
iage rates amongst infants in The Gambia. However, and since
t is known that pneumococcal carriage is not equally distributed
etween adults and children in this population, and is also variable
y age (for infants) and season [24], knowledge of precise carriage
ates (through nasopharyngeal swabs) at the time of vaccina-
ion may  have been informative. Inclusion of additional serotypes,
uch as those known to elicit a ‘weak’ response may  help explain
his observation. Indeed, previous research has identiﬁed serotype
B as being sensitive to modulation by infant feeding status[25],
ollowing vaccination with a conjugated vaccine. Such serotypes
ay, therefore, be more sensitive to nutritional exposures early in
ife.idered as a non-responder. For pneumococcal vaccination, post-vaccination
In interpreting the results presented here, consideration should
be given to the limitations of the current study. Much of the pro-
gramming literature in based on the follow up of cohorts of adults
for whom records from early-life are available. In The Gambia,
the UK Medical Research Council (MRC) has been maintaining
demographic and health-related records for three rural villages
since 1949 [26]. From 1976, these records have included detailed
information on maternal and infant health, allowing the study of
early-life predictors of current health within this population. How-
ever, as with many studies within this ﬁeld [27], the current study
suffered with considerable loss to follow up. A total of 78 (9%) of
the 858 subjects born during the study period were known to have
died prior to the start of ﬁeldwork. In addition, we were only able to
recruit 41% of the remaining 781 subjects available for follow up.
Whilst no differences were observed between the early-life data
for those subjects recruited and those available but not included,
these subjects only represent the surviving cohort. A major lim-
itation therefore is that the subjects recruited do not provide a
true representation of the original cohort; indeed, birth weights
amongst subjects who  were known to have died prior to follow up
were signiﬁcantly lower than those listed as available for follow
up (2.58 kg vs. 2.97 kg; ≤0.0001), perhaps indicating that the more
vulnerable subjects had already been lost from the cohort. A fur-
ther limitation of this study design is the lack of any direct measure
of early-life nutritional exposures in these subjects, including the
assessment of breast feeding practices. Whilst it might be assumed,
based on the literature from this population [28,29], that all sub-
jects would have been initially exclusively breast fed, followed by a
period of extensive breast feeding, given the literature on the asso-
ciation of early breast feeding practices and later antibody response
to vaccination e.g. [30], the lack of any detailed information must
be viewed as a limitation. Indeed, a strong criticism of much of the
programming ﬁeld is the lack of direct data assessing the impact
of nutritional exposures on health outcomes and the reliance on
observational data. Future work could usefully focus on cohorts for
whom direct measures of early-life nutritional exposures are avail-
able, such as the follow-up of randomized control trials of pre- or
post-natal nutritional supplementation, and also incorporate more
detailed measures of cellular immunity, to help interpret vaccine
response data.
To  understand the differential results between this study in The
Gambia and our previous observations from Pakistan, differences in
study design and cohort characteristics need consideration. Firstly,
the Gambian adults were signiﬁcantly younger than the adults in
Lahore (mean age 22.3 y vs. 29.4 y; p ≤ 0.0001) and so it is possi-
ble that their relative immaturity contributed to these ﬁndings.
This, however, seems unlikely since a further study in adolescents
from the Philippines (mean age 14.6 y) also observed a positive
association between birth weight and antibody response to the
same Vi vaccine [21]. In the current study, the geometric mean
4846 S.E.  Moore et al. / Vaccine 3
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(GM) post-vaccination anti-Vi antibody titre was  7.1 EU whilst in
Pakistan the GM was 5.9 EU (unadjusted difference between means
p = 0.1383): in both countries, post-vaccination levels were mea-
sured 14 days following vaccination. Although this difference in
GMs  is not statistically signiﬁcant, it is possible that it may  con-
tribute to the lack of an association in the current study, perhaps by
suggesting these young Gambian adult were able to mount an over-
all improved response to vaccination, diminishing the potential
impact of the early-life environment. The most consistent predic-
tor of antibody response to vaccination in the current study was
pre-vaccination antibody levels. However, pre-vaccination levels
were very similar between the two  studies (Gambia GM = 0.56 EU,
Pakistan GM = 0.53 EU; p = 0.8327) and so unlikely to explain the
lack of association with birth weight observed in the current study.
Relative differences in relation to the pneumococcal vaccine can-
not be compared since this vaccine was not used in the study in
Pakistan.
In the current study we  observed an interesting effect of a
number of contemporaneous measures and antibody response to
both vaccines. When combined in multiple regression analyses, the
measures shown to have the most signiﬁcant effects were serum
neopterin and plasma leptin levels, and pre-vaccination antibody
titres. Neopterin is a macrophage-derived protein commonly used
as a marker of immune activation, and elevated levels of periph-
eral blood neopterin indicate an unregulated cellular immune
response. In the current study, serum levels of neopterin inde-
pendently and positively predicted antibody response to serotypes
1 and 5 of the pneumococcal vaccine, but not to serotypes 14
and 23F or the response to the Vi vaccine. Although it is difﬁ-
cult to explain why individuals with elevated immune activation
responded more effectively to these two  serotypes only, we specu-
late that an enhanced vaccine response in subjects could be the
result of a co-stimulatory effect of an already elevated state of
immune activation. Whether such an effect has any longer term
implication on antibody titres, remains to be determined.
Leptin, a primarily adipocyte-derived hormone, was positively
correlated with serotype 14 of the pneumococcal vaccine but not
with the response to any other serotypes or the Vi vaccine. Leptin
levels correlate with body fat mass and leptin has more recently
been implicated as a central mediator connecting nutrition to
immunity [2]. Data from animal models have suggested that leptin
may mediate the effects of malnutrition on T cell function [31,32],
although little data currently exists to suggest that these effects
translate into compromised speciﬁc immune responses in mal-
nourished humans (e.g. [33]). Further work may  be warranted to
help understand the speciﬁc relationship between plasma leptin
levels and antibody response to serotype 14 of the pneumococcal
vaccine.
With the exception of antibody response to serotype 23F of the
pneumococcal vaccine, a highly signiﬁcant effect of pre-vaccination
antibody levels on post-vaccination titres was observed for both
vaccines. Pre-vaccination antibody titres are a consequence of
previous exposure to the vaccine antigens; for pneumococcal
serotypes this is mainly via exposure to the same or similar
serotypes encountered during nasopharyngeal carriage. A longi-
tudinal study of households in the UK showed strong immune
response to the carriage serotype, supporting the assumption that
natural immunity to Streptococcus pneumoniae is induced by expo-
sure to S. pneumoniae [34].
In  conclusion, we  have shown that antibody response to 2
polysaccharide vaccines is not inﬂuenced by the birth weight, size
in infancy or season of birth in rural Gambia, suggesting that young
Gambian adults are able to mount an adequate response to both
vaccines, irrespective of their early life environment. In addition to
the predictive capacity of pre-vaccination antibody levels, these
data suggest a role of immune activation and plasma leptin in
S.E. Moore et al. / Vaccine 30 (2012) 4842– 4848 4847
Table 5
Association between early-life variables and post-vaccination antibody concentrations.
Vi Type 1 Type 5 Type 14 Type 23F
 ˇ p-Value  ˇ p-Value  ˇ p-Value  ˇ p-Value  ˇ p-Value
Birth weight −0.246 0.210 −0.019 0.166 −0.056 0.645 0.015 0.905 −0.120 0.393
−0.222  0.124 −0.131 0.262 −0.008 0.938 0.165 0.185 −0.011 0.927
−0.246  0.210 −0.156 0.266 0.021 0.413 0.015 0.905 −0.120 0.393
Low  birth weight −0.200  0.415 −0.156 0.375 −0.159 0.292 −0.180 0.252 0.025 0.889
−0.008  0.966 −0.051 0.730 −0.139 0.292 −0.272 0.065 −0.090 0.543
−0.200  0.415 −0.183 0.297 −0.191 0.223 −0.180 0.252 0.025 0.889
Small  for gestational age 0.056 0.814 −0.032 0.849 −0.203 0.182 −0.164 0.280 0.242 0.146
0.098  0.568 −0.113 0.416 −0.217 0.100 −0.179 0.187 −0.080 0.584
0.056  0.814 −0.034 0.837 −0.167 0.274 −0.234 0.117 0.242 0.146
Early  catch-up growth −0.011 0.892 −0.025 0.674 −0.059 0.272 −0.140 0.009 −0.006 0.920
0.027  0.662 0.024 0.630 −0.042 0.391 −0.121 0.015 0.026 0.645
−0.011  0.892 0.006 0.926 −0.035 0.521 −0.118 0.026 −0.006 0.920
Infant  weight at 12 months −0.045 0.567 −0.086 0.132 −0.071 0.151 −0.134 0.008 −0.073 0.204
−0.026  0.655 −0.019 0.697 −0.025 0.566 −0.102 0.054 0.601 0.876
−0.045  0.567 −0.058 0.316 −0.090 0.078 −0.134 0.008 −0.073 0.204
Season  of birth 0.075 0.652 0.147 0.218 0.048 0.642 0.234 0.028 −0.058 0.630
−0.031  0.802 0.092 0.350 −0.003 0.975 0.223 0.021 −0.076 0.444
0.075  0.652 0.135 0.254 0.031 0.771 0.234 0.028 −0.058 0.630
Data in italics in ﬁrst row represents unadjusted results from multiple linear regression analysis, data in second row represents analysis adjusting for contemporary variables
correlated with antibody response to vaccination. Data in third row represents analysis adjusting for contemporary variables correlated with antibody response to vaccination
but  excluding pre-vaccination antibody titres.
Low birth weight–binary variable of subjects with a birthweight of <2.5 kg vs. subjects with a birth weight of ≥2.5 kg.
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